Hemolytic uremic syndrome associated with Denys-Drash syndrome

被引:15
|
作者
Sherbotie, JR
van Heyningen, V
Axton, R
Williamson, K
Finn, LS
Kaplan, BS [1 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
基金
英国医学研究理事会;
关键词
hemolytic uremic syndrome; Denys-Drash syndrome; diffuse mesangial sclerosis; Wilms' tumor; pseudohermaphroditism; WT1; mutation;
D O I
10.1007/s004670000389
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The Denys-Drash syndrome is defined by the occurrence of combinations of pseudohermaphroditism, nephrotic syndrome with diffuse mesangial sclerosis, Wilms' tumor, and constitutional mutations in the WT1 suppressor gene. Most patients develop end-stage renal failure. Atypical hemolytic uremic syndrome (HUS) is defined by onset of acute hemolytic anemia with fragmented erythrocytes, thrombocytopenia, and renal failure in the absence of a gastrointestinal prodromal illness of bloody diarrhea. The purpose of this report is to describe the occurrence of features of atypical HUS and Denys-Drash syndrome in two African-American boys aged 13 and 16 months. Each had nephrotic syndrome, diffuse mesangial sclerosis, and WT1 point mutations. Both had grade III hypospadias and undescended testes. They had normal serum creatinine concentrations and hematology a month before presenting with HUS, Stool cultures for Escherichia coli O157:H7 were negative. Each patient has been transplanted with cadaver kidneys without recurrence of HUS.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 50 条
  • [1] Hemolytic uremic syndrome associated with Denys-Drash syndrome
    J. R. Sherbotie
    V. van Heyningen
    R. Axton
    K. Williamson
    L. S. Finn
    B. S. Kaplan
    Pediatric Nephrology, 2000, 14 : 1092 - 1097
  • [2] Denys-Drash syndrome
    Roca, N.
    Cruz, A.
    Munoz, M.
    Madrid, A.
    Lara, E.
    Vilalta, R.
    Chocron, S.
    Ariceta, G.
    PEDIATRIC NEPHROLOGY, 2017, 32 (05) : 912 - 912
  • [3] Denys-Drash Syndrome
    Grewal, Shivraj S.
    Towbin, Richard B.
    Li, Yinan
    Geller, James I.
    Towbin, Alexander J.
    APPLIED RADIOLOGY, 2021, 50 (05) : 61 - 63
  • [4] THE DENYS-DRASH SYNDROME
    MUELLER, RF
    JOURNAL OF MEDICAL GENETICS, 1994, 31 (06) : 471 - 477
  • [5] Denys-Drash syndrome
    Lin, HC
    Lin, SK
    Wen, MC
    Tseng, CF
    Fu, LS
    Chi, CS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (01) : 71 - 74
  • [6] Management of Denys-Drash Syndrome
    Sagoyan, G.
    Rubanskaya, M.
    Rubanskiy, M.
    Suleymanova, A.
    Kazancev, A.
    Kirgizov, K.
    Varfolomeeva, S.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S251 - S252
  • [7] Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report
    Alge, Joseph L.
    Wenderfer, Scott E.
    Hicks, John
    Bekheirnia, Mir Reza
    Schady, Deborah A.
    Kain, Jamey S.
    Braun, Michael C.
    BMC NEPHROLOGY, 2017, 18
  • [8] Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report
    Joseph L. Alge
    Scott E. Wenderfer
    John Hicks
    Mir Reza Bekheirnia
    Deborah A. Schady
    Jamey S. Kain
    Michael C. Braun
    BMC Nephrology, 18
  • [9] CYCLOSPORINE RESPONSIVENESS IN DENYS-DRASH SYNDROME
    Wasilewska, A.
    Kuroczycka-Saniutycz, E.
    Taranta-Janusz, K.
    ACTA PAEDIATRICA, 2011, 100 : 52 - 53
  • [10] Denys-Drash syndrome (DDS): question
    Alomari, Ahmad I.
    Tham, Jacques C.
    PEDIATRIC NEPHROLOGY, 2006, 21 (09) : 1237 - 1240